Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis

Kidney International, Supplement

Volumn 64, Issue 88, 2003, Pages

  Dratwa, Max ^b   Wilkie, Martin ^b   Ryckelynck, Jean Philippe ^b   Ter Wee, P M ^b   Rutherford, Peter ^b   Michel, Catherine ^b   Hopwood, Alexandra ^a   Curtis, Lynne ^b   Denys, Nicolas ^b   Divino Filho, Jose C ^b   Faict, Dirk ^b  

^a Baxter Healthcare Ltd   (United Kingdom)

^b NONE

Author keywords

Acidosis; Alkalosis; APD; Bicarbonate; Bicarbonate lactate; Biocompatibility; Buffer; Calcium; Lactate; Peritoneal dialysis

Indexed keywords

BICARBONATE; DIALYSIS FLUID; DIANEAL; LACTIC ACID; PHYSIONEAL 35 FLUID; PHYSIONEAL 40 FLUID; UNCLASSIFIED DRUG; CALCIUM;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BALANCE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXCIPIENT COMPATIBILITY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; PAIN ASSESSMENT; PATIENT MONITORING; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; AUTOMATION; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; GAS; PAIN; PATIENT SATISFACTION; ULTRAFILTRATION; VEIN;

AUTOMATION; BICARBONATES; CALCIUM; DIALYSIS SOLUTIONS; GASES; HUMANS; LACTIC ACID; PAIN; PATIENT SATISFACTION; PERITONEAL DIALYSIS; QUESTIONNAIRES; ULTRAFILTRATION; VEINS;

EID: 0344011069     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.08812.x     Document Type: Article

References (20)

1. BOEN ST: Kinetics of peritoneal dialysis. A comparison with the artificial kidney. Medicine (Baltimore) 40:243-287, 1961
2. COLES GA, O'DONOGHUE DJ, PRITCHARD N, et al: A controlled trial of two bicarbonate-containing dialysis fluids for CAPD - Final report. Nephrol Dial Transplant 13:3165-3171, 1998
3. FERIANI M, BIASIOLI S, BORIN D, et al: Bicarbonate solutions for peritoneal dialysis: A reality. Int J Artif Organs 8:57-58, 1985
4. DE FIJTER CWH, VERBRUGH HA, PETERS EDJ, et al: In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 39:75-80, 1993
5. MACKENZIE RK, HOLMES CJ, MOSELY A, et al: Bicarbonate/lactate-and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFα secretion. J Am Soc Nephrol 9:1499-1506, 1998
6. MILLAR DJ, HOLMES CJ, FAICT D, DAWNAY A: Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation. Adv Perit Dial 14:191-194, 1998
7. SCHAMBYE HT, PEDERSEN FB, WANG P: Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: A cytotoxicity test of CAPD solutions and effluents. Adv Perit Dial 20:41-46, 1992
8. SCHAMBYE HT, PEDERSEN FB, CHRISTENSEN HK, et al: The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios. Perit Dial Int 13(Suppl 2):116-118, 1993
9. OTTE K, GONZALEZ MT, BAJO MA, et al: Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution. Perit Dial Int 23:138-145, 2003
10. MACTIER RA, SPROSEN TS, GOKAL R, et al: Bicarbonate and bicarbonate/lactate PD solutions for the treatment of infusion pain. Kidney Int 53:1061-1067, 1998
11. TRANAEUS A, for The Bicarbonate/lactate Study Group: A long term study of a bicarbonate/lactate based peritoneal dialysis solution - Clinical benefits. Perit Dial Int 20(5):516-523, 2000
12. CARRASCO AM, BAJO RUBIO MA, SANCHEZ TOMERO JA, et al: Acidosis correction with a new 25 mmol/L bicarbonate/15 mmol/L lactate peritoneal dialysis solution. Peril Dial Int 21:546-553, 2001
13. Institute of Child Health: Topic E - Guidelines for good clinical practice. Step 5, Consolidated guideline. 1996 www.emea.eu.int/ pdfs/riuman/ich/01395en.pdf
14. GUYTON AC: Functional organization of the body and control of the internal environment, in Textbook of Medical Physiology (chapter 1), edited by Guyton AC, Hall JE. Philadelphia, WB Saunders, 2000, pp 2-8
15. GAMBINO, SR, ASTRUP P, BATES RG, et al: Report of the ad hoc committee on acid-base methodology. Am J Clin Pathol 46(3):376-381, 1966
16. GENNARI FJ: Acid-base considerations in end-stage renal disease, in Principles and Practice of Dialysis (chapter 23) edited by Henrich WL, Baltimore, Lippincott, Williams & Wilkins, 1999, pp. 341-356
17. National Kidney Foundation: Nutrition guideline 14: Management of acid-base status. DOQI Guidelines 2000 http://www. kidney.org/professionals/ doqi/guidelines/nut_a14.html
18. HUTCHISON AJ, WERE AJ, BOULTON HF, et al: Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: Improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations. Nephron 72(1):52-58, 1996
19. MONTENEGRO J, SARACHO R, AGUIRRE R, MARTINEZ I: Calcium mass transfer in CAPD: The role of convective transport. Nephrol Dial Transplant 8(11):1234-1236, 1993
20. HEIMBÜRGER O, WANIEWSKI J, WANG T, et al: Peritoneal transport with lactate 40 mmol/L (L) vs bicarbonate/lactate 25/15 mmol/L (BL) dialysis fluids. Perit Dial Int 19(Suppl 1):S7, 1999